Good Clinical Practice Guide
Results 1 to 2 of 2

Thread: EU marketed drug unlicenced in UK and used as an IMP

Hybrid View

Previous Post Previous Post   Next Post Next Post
  1. #1

    EU marketed drug unlicenced in UK and used as an IMP

    If a drug has a marketing authorisation in Germany but has not been licenced in the UK, what is the position regarding the use of this as an IMP? It is available from a distributer in the UK as commercial product with an English label. Would we require evidence of an MIA (IMP) from the manufacturer?

  2. #2
    Forum Member
    Join Date
    Nov 2011
    Location
    London
    Posts
    26
    Dear Linda,
    If the drug is licenced in EU, you dont need any evidence of MIA (IMP), but you must need english version of SmPC. As you can see the proof of product licence number in the SmPC. But you need a copy of invoice to show that you bought it from approved supplier. Hope this helps.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •